SPIRO HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

Provided are a spiro heterocyclic compound, a preparation method therefor and use thereof. The spiro heterocyclic compound is represented by formula I. The compound has inhibitory activity on RORγt, can effectively inhibit the RORγt protein receptor, thereby regulating the differentiation of Th17 ce...

Full description

Saved in:
Bibliographic Details
Main Authors HUO, Guoyong, WANG, Qian, ZHANG, Bingbin, SHU, Sijie, XIA, Guangxin, SHI, Chen, XIANG, Zhijun, ZHAO, Yongxin, LI, Lingwen, WU, Guosheng, KE, Ying, LIANG, Tao
Format Patent
LanguageChinese
English
French
Published 12.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are a spiro heterocyclic compound, a preparation method therefor and use thereof. The spiro heterocyclic compound is represented by formula I. The compound has inhibitory activity on RORγt, can effectively inhibit the RORγt protein receptor, thereby regulating the differentiation of Th17 cells, inhibiting the generation of IL-17, and then treating related autoimmune diseases mediated by RORγt. L'invention concerne un composé spiro hétérocyclique, son procédé de préparation et son utilisation. Le composé spiro hétérocyclique est représenté par la formule I. Le composé a une activité inhibitrice sur RORγt, peut inhiber efficacement le récepteur de la protéine RORγt, ce qui permet de réguler la différenciation de cellules Th17, d'inhiber la génération d'IL-17, puis de traiter des maladies auto-immunes associées médiées par RORγt. 提供了一种螺杂环类化合物、其制备方法及应用。所述螺杂环类化合物如式I所示。该类化合物对RORγt具有抑制活性,可有效抑制RORγt蛋白受体,从而调控Th17细胞的分化,抑制IL-17的产生,进而治疗RORγt介导的相关自身免疫类疾病。
Bibliography:Application Number: WO2021CN129049